The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure
- PMID: 7479784
- PMCID: PMC40796
- DOI: 10.1073/pnas.92.22.10359
The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure
Abstract
Although the incidence of Gram-positive sepsis has risen strongly, it is unclear how Gram-positive organisms (without endotoxin) initiate septic shock. We investigated whether two cell wall components from Staphylococcus aureus, peptidoglycan (PepG) and lipoteichoic acid (LTA), can induce the inflammatory response and multiple organ dysfunction syndrome (MODS) associated with septic shock caused by Gram-positive organisms. In cultured macrophages, LTA (10 micrograms/ml), but not PepG (100 micrograms/ml), induces the release of nitric oxide measured as nitrite. PepG, however, caused a 4-fold increase in the production of nitrite elicited by LTA. Furthermore, PepG antibodies inhibited the release of nitrite elicited by killed S. aureus VSports手机版. Administration of both PepG (10 mg/kg; i. v. ) and LTA (3 mg/kg; i. v. ) in anesthetized rats resulted in the release of tumor necrosis factor alpha and interferon gamma and MODS, as indicated by a decrease in arterial oxygen pressure (lung) and an increase in plasma concentrations of bilirubin and alanine aminotransferase (liver), creatinine and urea (kidney), lipase (pancreas), and creatine kinase (heart or skeletal muscle). There was also the expression of inducible nitric oxide synthase in these organs, circulatory failure, and 50% mortality. These effects were not observed after administration of PepG or LTA alone. Even a high dose of LTA (10 mg/kg) causes only circulatory failure but no MODS. Thus, our results demonstrate that the two bacterial wall components, PepG and LTA, work together to cause systemic inflammation and multiple systems failure associated with Gram-positive organisms. .
References (V体育平台登录)
-
- Eur J Pharmacol. 1993 Nov 30;250(1):157-60 - "VSports" PubMed
-
- J Gen Microbiol. 1993 Nov;139(11):2659-65 - PubMed
-
- Infect Immun. 1995 Apr;63(4):1165-72 - PubMed
-
- J Med Microbiol. 1995 Jan;42(1):43-7 - PubMed
-
- Br J Pharmacol. 1995 Mar;114(6):1317-23 - "VSports最新版本" PubMed
"VSports app下载" Publication types
MeSH terms
- Actions (V体育官网入口)
- VSports手机版 - Actions
- Actions (VSports手机版)
- V体育官网入口 - Actions
- Actions (V体育2025版)
- V体育ios版 - Actions
- "V体育官网入口" Actions
- "VSports在线直播" Actions
- Actions (VSports最新版本)
Substances
- "V体育平台登录" Actions
- "V体育安卓版" Actions
- "VSports手机版" Actions
- "VSports手机版" Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
VSports最新版本 - Medical
